NR4A1 and breast cancer: Recent studies have identified some adverse prognostic factors associated with survival in patients with T1-2N1 breast cancer, including young age, greater lymph node disease burden, large tumor size, high histological grade, lymphovascular invasion, and negative hormone receptors (3, 7, 14, 15, 17, 20–27).